HDAC1 and Cognitive impairment: Furthermore, this study showed that the HDAC inhibitor SAHA alleviated axonal injury and cognitive impairment in rats with SAH by elevating TDP-43 degradation by enhancing the acetylation of HSP70 by inhibiting HDAC1 enzymatic activity.